Pharmerging Markets and the New Geography of Pharmaceutical Industry
Growth, localization and supply chain resilience in emerging pharmaceutical regions
Author
Cristiana Bernini, MakingLife
DOI
https://doi.org/10.5281/zenodo.20160947
Zenodo record
https://zenodo.org/records/20160947
License
Creative Commons Attribution–NonCommercial 4.0 International (CC BY-NC 4.0)
Abstract
Emerging pharmaceutical markets are no longer peripheral demand pools for products developed, manufactured and priced elsewhere. They are becoming strategic regions where demographic pressure, wider access to care, industrial policy, local manufacturing and geopolitical risk increasingly converge.
This working paper examines the changing role of pharmerging markets across Asia, Africa, Latin America, the Gulf region, Central-Eastern Europe and Turkey. It argues that the relevant issue is the function these markets are beginning to perform within the global pharmaceutical value chain: end markets, manufacturing platforms, regional hubs, fill-finish locations, technology-transfer environments or combinations of these roles.
For European and Italian life science companies, the opportunity is significant but selective. The most defensible strategies are likely to be based on partnership, regulatory competence, quality manufacturing, local presence, technology transfer and a careful reading of access systems, rather than on export alone.
Read the working paper on Zenodo
About this working paper
This paper belongs to MakingLife Working Papers | Pharma Science & Industry Series, a research-based editorial series dedicated to the industrial, regulatory and strategic transformation of the pharmaceutical and life sciences sectors.
The paper is published in open access on Zenodo, with DOI, structured metadata, bibliography and a non-commercial Creative Commons license.
MakingLife Working Papers is not a scientific journal or a peer-reviewed publication. It is a series of documented, citable analytical contributions developed within the MakingLife editorial ecosystem.
Suggested citation
Bernini, C. (2026). Pharmerging Markets and the New Geography of Pharmaceutical Industry: Growth, localization and supply chain resilience in emerging pharmaceutical regions. MakingLife Working Papers, Pharma Science & Industry Series, Working Paper No. 1. https://doi.org/10.5281/zenodo.20160947
Keywords
pharmerging markets, pharmaceutical industry, pharmaceutical manufacturing, health policy, supply chain resilience, localization, emerging markets, strategic autonomy, life sciences, market access
